Posts

Showing posts from May, 2026

Cold Chain Requirements for Infertility Injectables: A Guide for Distributors and Stockists

The demand for infertility treatments in India is increasing every day. The demand is impacted by the  IVF treatments, late pregnancies, hormonal disorders, and lifestyle-related fertility. The infertility injectables play an important role in fertility treatments. They need proper storage and transport conditions. The distributors and stockists should know about the cold chain requirements for infertility injectables. It will help them to maintain the quality of the product and patient safety. Infertility injectables are temperature-sensitive. A small fluctuation in temperature can impact the medicine. That is why maintaining a proper cold chain system is essential during the delivery. Understanding Cold Chain Management Cold chain management is the process of storing and transporting medicines at a proper temperature. Most infertility injectables need a temperature between 2°C and 8 °C. The medicines can loose it quality if exposed to heat, freezing conditions, or direct sunlight...

Building a Reliable Gynaecology & Infertility Medicine Portfolio: What Clinics and Distributors Should Expect

  The demand for therapeutic gynae and infertility medicines in India is rising rapidly due to increased awareness, delayed pregnancies, etc. The advancements in science and technology have also become one of the contributing factors behind the seamless expansion of the infertility drug market in India.  According to Research and Markets, the gynecology market is growing at a CAGR of 5%, opening doors for business entrepreneurs. However, before diving in, clinics and distributors need to invest in a reliable product portfolio. This is considered not just a business strategy, but it’s a responsibility toward improving women’s health outcomes.  In this blog, we are going to highlight what you should expect when partnering with a trusted gynecology medicine supplier in India and how to build a portfolio that ensures long-term growth and credibility.  Building a Reliable Gynaecology and Infertility Medicine Portfolio Before selecting portfolio elements, clinics and dist...

Role of hCG Trigger in ART Cycles: Formulation Choices and Clinical Outcomes- Adorefem

  Role of hCG Trigger in ART Cycles: ART refers to the Assisted Reproductive Technology, which is included in certain medical procedures related to IVF and ICSI. In these cycles, the most critical step is the ovulation trigger, where the hCG hormone plays a vital role. This hormone is widely used to induce the final oocyte maturation to ensure that the eggs are ready for fertilization. The choice and the clinical application of the hCG trigger are important, as they can significantly influence the outcomes of a treatment, making modern clinical practices necessary.  What is hCG Trigger and its Mechanism in ART Cycles? The human chorionic gonadotropin (hCG) trigger in the ART cycles is carefully administered to induce the final step of maturation in the ovarian follicles after a controlled ovarian stimulation. This is a crucial step, which is why it's carefully monitored so that the follicles, which are in the developing stage, reach an optimal size.  The hCG hormone mimic...

Gynaecology Medicines Segment in India: Market Trends Distributors Should Track in 2026-Adorefem

The Gynaecology Medicines Segment is a branch of specialised healthcare products focused on the treatment, diagnosis, and prevention of medical conditions related to the female reproductive system. This includes the uterus, vagina, ovaries, fallopian tubes, and the breasts. This medical segment covers women’s health from puberty to menopause. The Gynaecology Medicines Segment in India is a vast sector that deals in multiple therapy areas, such as PCOS, reproductive health, preventive care and screening, infections, pelvic floor issues, endometriosis & fibroids, gynaecologic oncology, and fertility and reproductive surgery.  There is a rise in the women’s healthcare sector primarily due to increased health awareness. According to Biospectrum India, the women's healthcare sector in India is expected to reach $72 billion by the year 2023, with a compound annual growth rate of 9.7%. This growth influences the market and creates new opportunities for pharma distributors. Particula...